Dr. Athiya Agarwal has filed a formal disclosure regarding the acquisition of shares in Dr. Agarwal’s Health Care Limited via an inter-se transfer from promoter Dr. Anosh Agarwal. The transfer was executed as a gift on March 04, 2026. Following the transaction, Dr. Athiya Agarwal’s total holding in the company has increased to 1,26,61,975 shares, representing 4.00% of the total voting capital.
Filing Details and Transaction Overview
This document serves as a formal disclosure concerning a change in shareholding in Dr. Agarwal’s Health Care Limited (TC), submitted by Dr. Athiya Agarwal. The transaction involved the acquisition of equity shares through an inter-se off-market transfer between promoters, specifically executed by way of a gift.
The transferor in this transaction was identified as Dr. Anosh Agarwal. The effective date of the acquisition/receipt of intimation for this transfer was March 04, 2026.
Shareholding Before the Acquisition
Prior to the acquisition via gift, the holding of Dr. Athiya Agarwal in the Target Company was as follows:
- Shares carrying voting rights: 1,05,46,795, equivalent to 3.33% of the total share capital.
- Total holding (a+b+c+d): 1,05,46,795 (3.33%).
Details of Shares Acquired/Sold
The details of the shares transferred to Dr. Athiya Agarwal are summarized below:
- Shares carrying voting rights acquired/sold: 21,15,180 shares.
- Percentage acquired: 0.67% of the total share capital.
- Total acquisition (a+b+c+/-d): 21,15,180 shares (0.67%).
Shareholding After the Acquisition
Following the completion of the inter-se transfer, the resultant holding of Dr. Athiya Agarwal in the company is:
- Shares carrying voting rights: 1,26,61,975 shares.
- New percentage holding: 4.00% of the total share capital.
- Total holding (a+b+c+d): 1,26,61,975 shares (4.00%).
Capital Structure Confirmation
The capital structure of Dr. Agarwal’s Health Care Limited remained consistent before and after the transaction:
- Equity share capital before and after the said acquisition/sale: 31,68,07,506 equity shares of Re. 1/- each, aggregating to Rs. 31,68,07,506.
- Total diluted share/voting capital post-acquisition: 31,68,07,506 equity shares.
Source: BSE
